-
Anthera Soars 30% On Kidney Treatment Data
Wednesday, December 7, 2016 - 1:44pm | 335Shares of Anthera Pharmaceuticals Inc (NASDAQ: ANTH), a nano-cap bio-pharmaceutical company that focuses on developing and commercializing products to treat serious diseases, soared higher by more than 30 percent on Wednesday. Anthera announced on Tuesday positive data from its Phase 2 BRIGHT-...